medigraphic.com
ISSN 2992-8036 (Digital)
ISSN 2306-4102 (Impreso)
Órgano Oficial del Colegio Mexicano de Ortopedia y Traumatología

2013, Número S1

<< Anterior Siguiente >>

Acta Ortop Mex 2013; 27 (S1)


Tratamiento de infecciones articulares periprotésicas por hongos o gérmenes atípicos

Idioma: Español
Referencias bibliográficas: 47
Paginas: 149-153
Archivo PDF: 150.78 Kb.


FRAGMENTO

Pregunta 1: ¿Cuál es la definición de infección articular periprotésica (IAP) producida por hongos o gérmenes atípicos?

Consenso: Una infección por hongos o gérmenes atípicos es aquella infección articular posterior a una artroplastía causada por este tipo de microorganismos.
Votación de los delegados: de acuerdo, 89%; en desacuerdo, 7%; abstenciones, 4%. (Consenso fuerte.)


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Azzam K, Parvizi J, Jungkind D, et al: Microbiological, clinical, and surgical features of fungal prosthetic joint infections: a multi-institutional experience. J Bone Joint Surg Am. 2009; 91(Suppl 6): 142-149.

  2. Kohli R, Hadley S: Fungal arthritis and osteomyelitis. Infect Dis Clin North Am. 2005; 19(4): 831-851.

  3. Phelan DM, Osmon DR, Keating MR, Hanssen AD: Delayed reimplantation arthroplasty for candidal prosthetic joint infection: a report of 4 cases and review of the literature. Clin Infect Dis. 2002; 34(7): 930-938.

  4. Darouiche RO, Hamill RJ, Musher DM, Young EJ, Harris RL: Periprosthetic candidal infections following arthroplasty. Rev Infect Dis. 1989; 11(1): 89-96.

  5. Hennessy MJ: Infection of a total knee arthroplasty by Candida parapsilosis. A case report of successful treatment by joint reimplantation with a literature review. Am J Knee Surg. 1996; 9(3): 133-136.

  6. Koch AE: Candida albicans infection of a prosthetic knee replacement: a report and review of the literature. J Rheumatol. 1988; 15(2): 362-365.

  7. Lambertus M, Thordarson D, Goetz MB: Fungal prosthetic arthritis: presentation of two cases and review of the literature. Rev Infect Dis. 1988; 10(5): 1038-1043.

  8. Selmon GP, Slater RN, Shepperd JA, Wright EP: Successful 1-stage exchange total knee arthroplasty for fungal infection. J Arthroplasty. 1998; 13(1): 114-115.

  9. Simonian PT, Brause BD, Wickiewicz TL: Candida infection after total knee arthroplasty. Management without resection or amphotericin B. J Arthroplasty. 1997; 12(7): 825-829.

  10. Wada M, Baba H, Imura S: Prosthetic knee Candida parapsilosis infection. J Arthroplasty. 1998; 13(4): 479-482.

  11. Cardinal E, Braunstein EM, Capello WN, Heck DA: Candida albicans infection of prosthetic joints. Orthopedics. 1996; 19(3): 247-251.

  12. Badrul B, Ruslan G: Candida albicans infection of a prosthetic knee replacement: a case report. Med J Malaysia. 2000; 55(Suppl C): 93-96.

  13. Brooks DH, Pupparo F: Successful salvage of a primary total knee arthroplasty infected with Candida parapsilosis. J Arthroplasty. 1998; 13(6): 707-712.

  14. Austin KS, Testa NN, Luntz RK, Greene JB, Smiles S: Aspergillus infection of total knee arthroplasty presenting as a popliteal cyst. Case report and review of the literature. J Arthroplasty. 1992; 7(3): 311-314.

  15. Ceffa R, Andreoni S, Borre S, et al: Mucoraceae infections of antibiotic-loaded cement spacers in the treatment of bacterial infections caused by knee arthroplasty. J Arthroplasty. 2002; 17(2): 235-238.

  16. Dumaine V, Eyrolle L, Baixench MT, et al: Successful treatment of prosthetic knee Candida glabrata infection with caspofungin combined with flucytosine. Int J Antimicrob Agents. 2008; 31(4): 398-399.

  17. Fukasawa N, Shirakura K: Candida arthritis after total knee arthroplasty –a case of successful treatment without prosthesis removal. Acta Orthop Scand. 1997; 68(3): 306-307.

  18. Gaston G, Ogden J: Candida glabrata periprosthetic infection: a case report and literature review. J Arthroplasty. 2004; 19(7): 927-930.

  19. Iskander MK, Khan MA: Candida albicans infection of a prosthetic knee replacement. J Rheumatol. 1988; 15(10): 1594-1595.

  20. Lackner M, De Man FH, Eygendaal D, et al: Severe prosthetic joint infection in an immunocompetent male patient due to a therapy refractory Pseudallescheria apiosperma. Mycoses. 2011; 54(Suppl 3): 22-27.

  21. Lazzarini L, Manfrin V, De Lalla F: Candidal prosthetic hip infection in a patient with previous candidal septic arthritis. J Arthroplasty. 2004; 19(2): 248-252.

  22. Lerch K, Kalteis T, Schubert T, Lehn N, Grifka J: Prosthetic joint infections with osteomyelitis due to Candida albicans. Mycoses. 2003; 46(11-12): 462-466.

  23. Levine M, Rehm SJ, Wilde AH: Infection with Candida albicans of a total knee arthroplasty. Case report and review of the literature. Clin Orthop Relat Res. 1988; (226): 235-239.

  24. Lim EV, Stern PJ: Candida infection after implant arthroplasty. A case report. J Bone Joint Surg Am. 1986; 68(1): 143-145.

  25. MacGregor RR, Schimmer BM, Steinberg ME: Results of combined amphotericin B-5-fluorcytosine therapy for prosthetic knee joint infected with Candida parapsilosis. J Rheumatol. 1979; 6(4): 451-455.

  26. Nayeri F, Cameron R, Chryssanthou E, Johansson L, Soderstrom C: Candida glabrata prosthesis infection following pyelonephritis and septicaemia. Scand J Infect Dis. 1997; 29(6): 635-638.

  27. Wu MH, Hsu KY: Candidal arthritis in revision knee arthroplasty successfully treated with sequential parenteral-oral fluconazole and amphotericin B-loaded cement spacer. Knee Surg Sports Traumatol Arthrosc. 2011; 19(2): 273-276.

  28. Anagnostakos K, Kelm J, Schmitt E, Jung J: Fungal periprosthetic hip and knee joint infections clinical experience with a 2-stage treatment protocol. J Arthroplasty. 2012; 27(2): 293-298.

  29. Marra F, Robbins GM, Masri BA, et al: Amphotericin B-loaded bone cement to treat osteomyelitis caused by Candida albicans. Can J Surg. 2001; 44(5): 383-386.

  30. Ruhnke M, Rickerts V, Cornely OA, et al: Diagnosis and therapy of Candida infections: joint recommendations of the German Speaking Mycological Society and the Paul-Ehrlich-Society for Chemotherapy. Mycoses. 2011; 54(4): 279-310.

  31. Wyman J, McGough R, Limbird R: Fungal infection of a total knee prosthesis: successful treatment using articulating cement spacers and staged reimplantation. Orthopedics. 2002; 25(12): 1391-1394; discussion 1394.

  32. Yang SH, Pao JL, Hang YS: Staged reimplantation of total knee arthroplasty after Candida infection. J Arthroplasty. 2001; 16(4): 529-532.

  33. Yilmaz M, Mete B, Ozaras R, et al: Aspergillus fumigatus infection as a delayed manifestation of prosthetic knee arthroplasty and a review of the literature. Scand J Infect Dis. 2011; 43(8): 573-578.

  34. Gottesman-Yekutieli T, Shwartz O, Edelman A, Hendel D, Dan M: Pseudallescheria boydii infection of a prosthetic hip joint –an uncommon infection in a rare location. Am J Med Sci. 2011; 342(3): 250-253.

  35. Buranapanitkit B, Oungbho K, Ingviya N: The efficacy of hydroxyapatite composite impregnated with amphotericin B. Clin Orthop Relat Res. 2005; (437): 236-241.

  36. Chandra J, Kuhn DM, Mukherjee PK, Hoyer LL, McCormick T, Ghannoum MA: Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol. 2001; 183(18): 5385-5394.

  37. Deelstra JJ, Neut D, Jutte PC: Successful treatment of Candida albicans-infected total hip prosthesis with staged procedure using an antifungal-loaded cement spacer. J Arthroplasty. 2013; 28(2): 374 e375-378.

  38. Goss B, Lutton C, Weinrauch P, Jabur M, Gillett G, Crawford R: Elution and mechanical properties of antifungal bone cement. J Arthroplasty. 2007; 22(6): 902-908.

  39. Grimsrud C, Raven R, Fothergill AW, Kim HT: The in vitro elution characteristics of antifungal-loaded PMMA bone cement and calcium sulfate bone substitute. Orthopedics. 2011; 34(8): e378-381.

  40. Harmsen S, McLaren AC, Pauken C, McLemore R: Amphotericin B is cytotoxic at locally delivered concentrations. Clin Orthop Relat Res. 2011; 469(11): 3016-3021.

  41. Rouse MS, Heijink A, Steckelberg JM, Patel R: Are anidulafungin or voriconazole released from polymethylmethacrylate in vitro? Clin Orthop Relat Res. 2011; 469(5): 1466-1469.

  42. Sealy PI, Nguyen C, Tucci M, Benghuzzi H, Cleary JD: Delivery of antifungal agents using bioactive and nonbioactive bone cements. Ann Pharmacother. 2009; 43(10): 1606-1615.

  43. Silverberg D, Kodali P, Dipersio J, Acus R, Askew M: In vitro analysis of antifungal impregnated polymethylmethacrylate bone cement. Clin Orthop Relat Res. 2002; (403): 228-231.

  44. Cunningham B, McLaren AC, Pauken C, McLemore R: Liposomal formulation increases local delivery of amphotericin from bone cement: a pilot study. Clin Orthop Relat Res. 2012; 470(10): 2671-2676.

  45. Miller RB, McLaren AC, Pauken C, Clarke HD, McLemore R: Voriconazole is delivered from antifungal-loaded bone cement. Clin Orthop Relat Res. 2013; 471(1): 195-200.

  46. Ostrosky-Zeichner L, Alexander BD, Kett DH, et al: Multicenter clinical evaluation of the (1- > 3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis. 2005; 41(5): 654-659.

  47. Fabry K, Verheyden F, Nelen G: Infection of a total knee prosthesis by Candida glabrata: a case report. Acta Orthop Belg. 2005; 71(1): 119-121.




2020     |     www.medigraphic.com